Spots Global Cancer Trial Database for Methylphenidate Treatment of Cancer-Related Fatigue
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Methylphenidate Treatment of Cancer-Related Fatigue
Official Title: Placebo Controlled Double Blind Study With Methylphenidate in Treatment of Adults With Cancer-Related Fatigue
Study ID: NCT00758407
Conditions
Study Description
Brief Summary: The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sonnenbergklinik, Bad Sooden-Allendorf, , Germany
Praxis Dr. Lathan, Dortmund, , Germany
Praxis Dr. Verpoort - Dr. Zeller, Hamburg, , Germany
Dr. J.-U. Rüffer, Köln, , Germany
Medizinische Fakultät der Universität Leipzig, Leipzig, , Germany
Medizinisches Versorgungszentrum - MOP, München, , Germany
Contact Details
Name: Manfred Heim, Prof.
Affiliation: Sonnenbergklinik, Hardstr. 13, D-37242 Bad Sooden-Allendorf
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
